Pfizer has announced another upgrade of its sterile injectables plant in Portage, Michigan, earmarking around $21 million for new air handling, sterilisation and utility systems.
The money is being spent on Building 41 of the Portage facility, which in total employs around 2,950 manufacturing staff and manufactures sterile injectables, liquids, semisolids and the active pharmaceutical ingredients used in various medicines.
Portage is also a key manufacturing location for Pfizer CentreSource, which supplies fine chemicals and ingredients to the Pfizer group and also carries out sterile, high-potency and custom contract manufacturing for third-party companies.
